Jan 22 (Reuters) - BrightPath Biotherapeutics Co Ltd :
* Says 4,500 units of its 12th series options were exercised to 450,000 shares of its common stock, during the period from Jan. 16 to Jan. 22
Source text in Japanese: goo.gl/JHEQvh
Further company coverage: (Beijing Headline News)
 